Profile picture

Doctor Pankaj Jariwala

Yashoda Hospital Hyderabad, Hyderabad (India)
Membership: FESC Member
Follow
Biography
ACADEMIC POSITIONS ● Ex Assistant Professor of Cardiology [NIMS] ● Former Associate Editor of Indian Heart Journal. ● Associate editor of Journal of Indian College of Cardiology. ● Invited faculty in various National and International Cardiology Conferences. ● Has conducted more than 250 educational CMEs for medical students and General practitioners. AWARDS RECEIVED > Received Best prize for ‘ Call for Clinical Case ’ at EuroPCR 2009 . ● Received ‘ Data scope (Maquet) IABP scholarship for case presentation’ at TCT 2009 2010 , San Francisco,USA. FELLOWSHIP ● Interventional fellowship programme at Washington Hospital Centre, Washington, DC, USA in Interventional Cardiology in Oct 2007. ● Fellowship in Interventional Cardiology at Institut Cardiovasculaire Paris Sud [ICPS], Massy, Paris, France from Oct. 2009 to Oct. 2010 PUBLICATIONS Published more than 100 articles in various National and International journals.
Logo ESC

Contributor content

The prevalence of risk factors and pattern of obstructive coronary artery disease in young indians (< 45 years) undergoing percutaneous coronary intervention: a gender-based multi-center study
Presentation
The prevalence of risk factors and pattern of obstructive coronary artery disease in young indians (< 45 years) undergoing percutaneous coronary intervention: a gender-based multi-center study
Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).
Presentation
Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).
Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).
Presentation
Safety and effectiveness of angiotensin receptor-neprilysin inhibitors in patients with heart failure with preserved ejection fraction (ARNI-PRESERVED study).
The ADDition of DAPAgliflozin to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory HFrEF
Presentation
The ADDition of DAPAgliflozin to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory HFrEF
Impact of DAPT duration on clinical outcome after stent implantation for coronary bifurcation lesions: Multicentre experience.
Presentation
Impact of DAPT duration on clinical outcome after stent implantation for coronary bifurcation lesions: Multicentre experience.

ESC 365 is supported by